It is commonly accepted that dietary habits and cardiometabolic disorders are connected to the composition of the gut microbiota. However, can we really generalize and predict health by screening faecal microorganisms? A study has taken the plunge and identified a vast range of correlations supporting this possibility.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Cani, P. D. Human gut microbiome: hopes, threats and promises. Gut 67, 1716–1725 (2018).
Cani, P. D. Gut microbiota - at the intersection of everything? Nat. Rev. Gastroenterol. Hepatol. 14, 321–322 (2017).
Asnicar, F. et al. Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals. Nat. Med. https://doi.org/10.1038/s41591-020-01183-8 (2021).
Le Chatelier, E. et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541–546 (2013).
Dao, M. C. et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65, 426–436 (2016).
Lagier, J. C. et al. Culture of previously uncultured members of the human gut microbiota by culturomics. Nat. Microbiol. 1, 16203 (2016).
Van Hul, M. et al. From correlation to causality: the case of Subdoligranulum. Gut Microbes 12, 1–13 (2020).
Depommier, C. et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat. Med. 25, 1096–1103 (2019).
Agus, A., Clement, K. & Sokol, H. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut https://doi.org/10.1136/gutjnl-2020-323071 (2020).
Acknowledgements
P.D.C. is senior research associate at FRS-FNRS (Fonds de la Recherche Scientifique) and acknowledges the support of grants from FNRS (Projet de Recherche PDR-convention: FNRS T.0030.21-P, FRFS-WELBIO: WELBIO-CR-2019C-02R).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
P.D.C. is the inventor on patent applications dealing with the use of A. muciniphila and its components in the treatment of metabolic disorders. P.D.C. is co-founder of A-Mansia biotech SA.
Rights and permissions
About this article
Cite this article
Cani, P.D., Van Hul, M. Do diet and microbes really ‘PREDICT’ cardiometabolic risks?. Nat Rev Endocrinol 17, 259–260 (2021). https://doi.org/10.1038/s41574-021-00480-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41574-021-00480-7
This article is cited by
-
The gut microbiota in obesity and weight management: microbes as friends or foe?
Nature Reviews Endocrinology (2023)
-
Contribution of the microbiome for better phenotyping of people living with obesity
Reviews in Endocrine and Metabolic Disorders (2023)